Queue questions: Ethics of COVID-19 vaccine prioritization
The rapid development of vaccines against COVID-19 represents a huge achievement, and offers hope of ending the global pandemic. At least three COVID-19 vaccines have been approved or are about to be approved for distribution in many countries. However, with very limited initial availability, only a...
| Autori: | ; ; |
|---|---|
| Tipo di documento: | Elettronico Articolo |
| Lingua: | Inglese |
| Verificare la disponibilità: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Pubblicazione: |
[2021]
|
| In: |
Bioethics
Anno: 2021, Volume: 35, Fascicolo: 4, Pagine: 348-355 |
| Notazioni IxTheo: | NCH Etica della medicina TK Età contemporanea |
| Altre parole chiave: | B
Immunization
B Covid-19 B pandemic ethics B prioritization B vaccination ethics |
| Accesso online: |
Accesso probabilmente gratuito Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1756658617 | ||
| 003 | DE-627 | ||
| 005 | 20211006154911.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210430s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.12858 |2 doi | |
| 035 | |a (DE-627)1756658617 | ||
| 035 | |a (DE-599)KXP1756658617 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |e VerfasserIn |0 (DE-588)1228634297 |0 (DE-627)1750529769 |4 aut |a Giubilini, Alberto | |
| 109 | |a Giubilini, Alberto | ||
| 245 | 1 | 0 | |a Queue questions |b Ethics of COVID-19 vaccine prioritization |
| 264 | 1 | |c [2021] | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The rapid development of vaccines against COVID-19 represents a huge achievement, and offers hope of ending the global pandemic. At least three COVID-19 vaccines have been approved or are about to be approved for distribution in many countries. However, with very limited initial availability, only a minority of the population will be able to receive vaccines this winter. Urgent decisions will have to be made about who should receive priority for access. Current policy in the UK appears to take the view that those who are most vulnerable to COVID-19 should get the vaccine first. While this is intuitively attractive, we argue that there are other possible values and criteria that need to be considered. These include both intrinsic and instrumental values. The former are numbers of lives saved, years of life saved, quality of the lives saved, quality-adjusted life-years (QALYs), and possibly others including age. Instrumental values include protecting healthcare systems and other broader societal interests, which might require prioritizing key worker status and having dependants. The challenge from an ethical point of view is to strike the right balance among these values. It also depends on effectiveness of different vaccines on different population groups and on modelling around cost-effectiveness of different strategies. It is a mistake to simply assume that prioritizing the most vulnerable is the best strategy. Although that could end up being the best approach, whether it is or not requires careful ethical and empirical analysis. | ||
| 601 | |a COVID-19 | ||
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a Immunization | |
| 650 | 4 | |a pandemic ethics | |
| 650 | 4 | |a prioritization | |
| 650 | 4 | |a vaccination ethics | |
| 652 | |a NCH:TK | ||
| 700 | 1 | |e VerfasserIn |0 (DE-588)1163621471 |0 (DE-627)102793496X |0 (DE-576)508091942 |4 aut |a Savulescu, Julian |d 1963- | |
| 700 | 1 | |a Wilkinson, Dominic |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 35(2021), 4, Seite 348-355 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnas |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:4 |g pages:348-355 |
| 856 | |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.12858 |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [deprecated] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1111/bioe.12858 |x Resolving-System |z lizenzpflichtig |3 Volltext |7 1 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12858 |x Verlag |z lizenzpflichtig |3 Volltext |7 1 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 3920247167 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1756658617 | ||
| LOK | |0 005 20211006154911 | ||
| LOK | |0 008 210430||||||||||||||||ger||||||| | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixzo | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| LOK | |0 936ln |0 1442053887 |a TK | ||
| LOK | |0 939 |a 30-04-21 |b l01 | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||
| REL | |a 1 | ||
| SUB | |a REL | ||
